FDA Update: Agency Issues Warnings to Companies Selling Dietary Supplements Claiming to Treat CVD

The U.S. Food and Drug Administration (FDA) issued warning letters on Nov. 17 to seven companies for "illegally selling dietary supplements that claim to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure."

The agency maintains that these products have not been evaluated to be safe or effective for their intended use and that selling these products with unproven claims to treat cardiovascular disease is a violation of the Federal Food, Drug, and Cosmetic Act. The warning letters were sent to Essential Elements (Scale Media Inc.), Calroy Health Sciences LLC, Iwi, BergaMet North America LLC, Healthy Trends Worldwide LLC (Golden After 50), Chambers' Apothecary, and Anabolic Laboratories, LLC.

Access the FDA press release to learn more.

Clinical Topics: Heart Failure and Cardiomyopathies, Prevention, Nonstatins, Acute Heart Failure, Diet

Keywords: ACC Advocacy, United States Food and Drug Administration, Cardiovascular Diseases, Laboratories, Dietary Supplements, Atherosclerosis, Heart Failure, Stroke

< Back to Listings